Alessandro Rambaldi

Sequential transplantation of allogeneic hematopoietic stem cells and liver in x-linked hyper-IgM syndrome: the role of CMV prophylaxis with letermovir

X-linked hyper-IgM syndrome (XHIM) is a rare inborn error of immunity caused by CD40 ligand deficiency, resulting in combined humoral and cellular immune dysfunction with susceptibility to opportunistic infections, particularly Cryptosporidium-associated sclerosing cholangitis. A...

Real‐world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial

Summary Venetoclax (VEN) plus hypomethylating agents (HMAs) represents the standard of care for newly diagnosed acute myeloid leukaemia (AML) patients unfit for intensive chemotherapy, but prospective real‐world observational data outside randomized clinical trials remain limited...